Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04508803
What this trial is testing

Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer

Who this might be right for
Treatment Efficacy
Fudan University 37
Early research (Phase 1)Study completedNCT01222546
What this trial is testing

Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Chugai Pharma Europe Ltd. 38
Not applicableNot Yet RecruitingNCT07505446
What this trial is testing

Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

Who this might be right for
Multi Drug Resistant OrganismsAntibiotic Resistance
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT00409188
What this trial is testing

Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)

Who this might be right for
Non-small Cell Lung Cancer
EMD Serono 1,513
Testing effectiveness (Phase 2)Study completedNCT02441686
What this trial is testing

Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dana-Farber Cancer Institute 46
Early research (Phase 1)Looking for participantsNCT07042100
What this trial is testing

Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
Sun Pharma Advanced Research Company Limited 177
Early research (Phase 1)Study completedNCT04322292
What this trial is testing

BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 9
Testing effectiveness (Phase 2)Study completedNCT02278133
What this trial is testing

Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations

Who this might be right for
Metastatic Colorectal Cancer
Array BioPharma 20
Not applicableStudy completedNCT00900406
What this trial is testing

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Vanderbilt-Ingram Cancer Center 190
Testing effectiveness (Phase 2)Looking for participantsNCT07605416
What this trial is testing

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

Who this might be right for
Plasma Cell Leukemia
National Cancer Institute (NCI) 74
Early research (Phase 1)Ended earlyNCT03582033
What this trial is testing

A Safety Study of SEA-BCMA in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Seagen Inc. 83
Testing effectiveness (Phase 2)WithdrawnNCT02072252
What this trial is testing

Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men

Who this might be right for
Depressive SymptomsAnxiety Generalized
Northwestern University
Early research (Phase 1)Study completedNCT00693433
What this trial is testing

Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT02519452
What this trial is testing

Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 120
Early research (Phase 1)Study completedNCT02364492
What this trial is testing

A Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of Relapse

Who this might be right for
Breast Neoplasms
Institut Pasteur 20
Testing effectiveness (Phase 2)Study completedNCT04055844
What this trial is testing

Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyeloid and Monocytic LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 14
Large-scale testing (Phase 3)Study completedNCT01984632
What this trial is testing

Barbed Suture in Single-port Laparoscopic Myomectomy

Who this might be right for
Uterine Myoma
CHA University 80
Early research (Phase 1)Study completedNCT04889287
What this trial is testing

Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
Bayer 16
Large-scale testing (Phase 3)Study completedNCT00090493
What this trial is testing

Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 4
Not applicableStudy completedNCT05212233
What this trial is testing

Financial Difficulty in Patients With Blood Cancer

Who this might be right for
Chronic Lymphocytic LeukemiaMultiple Myeloma
UNC Lineberger Comprehensive Cancer Center 218
Next Page